Cargando…
Tongxinluo Capsule Combined with Atorvastatin for Coronary Heart Disease: A Systematic Review and Meta-Analysis
INTRODUCTION: Coronary heart disease (CHD) is a common clinical cardiovascular disease, and its morbidity and mortality rates are increasing, which brings a serious burden to the family and society. Dyslipidemia is one of the most important risk factors for CHD. However, it is difficult to reduce bl...
Autores principales: | Liu, Qiao, Dong, Taiwei, Xi, Miaomiao, Gou, Licheng, Bai, Yang, Hou, Lian, Li, Min, Ou, Li, Miao, Feng, Wei, Peifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313336/ https://www.ncbi.nlm.nih.gov/pubmed/34335841 http://dx.doi.org/10.1155/2021/9413704 |
Ejemplares similares
-
Experimental evidence and network pharmacology-based analysis reveal the molecular mechanism of Tongxinluo capsule administered in coronary heart diseases
por: Li, Guode, et al.
Publicado: (2020) -
Tongxinluo enhances the effect of atorvastatin on the treatment of atherosclerosis with chronic obstructive pulmonary disease by maintaining the pulmonary microvascular barrier
por: Kuang, Xiangnan, et al.
Publicado: (2022) -
Tongxinluo capsule in combination with conventional therapies for stable angina pectoris: A meta-analysis and systematic review
por: Feng, Ruli, et al.
Publicado: (2023) -
Efficacy and Safety of Different Courses of Tongxinluo Capsule as Adjuvant Therapy for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Hui, Jiaqi, et al.
Publicado: (2022) -
Systematic Review of Tongxinluo Capsule on the Therapeutic Effect and Hemorheology of Patients with Transient Ischemic Attack
por: Yang, Peng, et al.
Publicado: (2021)